| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee99bed012c68e8f0e2720a085cac181 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6506a86844f34e3ab5a9e306e096deb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a2a2c220824c16b47275bbe1aedb24a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c826c004a55d93e5ec2cd56712b0aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8273aa8c91a7fcdae779cdcf7c82b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb2a03e551de1e19d94404b198798db6 |
| publicationDate |
2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020101586-A1 |
| titleOfInvention |
Controlled release propiverine formulations |
| abstract |
The present invention relates to controlled release pharmaceutical compositions for oral administration comprising propiverine or a pharmaceutically acceptable salt thereof. Particularly, the present invention relates to a pharmaceutical composition for oral administration with an enteric coating with an amount of the range between 0.5% to 2.5% by weight of core tablet. |
| priorityDate |
2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |